OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effects of a single dose of psilocybin on behaviour, brain 5-HT2A receptor occupancy and gene expression in the pig
Lene Lundgaard Donovan, Jens Vilstrup Johansen, Nídia Fernandez Ros, et al.
European Neuropsychopharmacology (2020) Vol. 42, pp. 1-11
Closed Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT2A Receptor Density in the Pig Brain
Nakul Ravi Raval, Annette Johansen, Lene Lundgaard Donovan, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 2, pp. 835-835
Open Access | Times Cited: 151

Biochemical Mechanisms Underlying Psychedelic-Induced Neuroplasticity
David E. Olson
Biochemistry (2022) Vol. 61, Iss. 3, pp. 127-136
Open Access | Times Cited: 80

Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experience
M. Madsen, Dea Siggaard Stenbæk, Albin Arvidsson, et al.
European Neuropsychopharmacology (2021) Vol. 50, pp. 121-132
Open Access | Times Cited: 93

Psychedelics and Neural Plasticity: Therapeutic Implications
Steven F. Grieco, Eero Ċastrén, Gitte M. Knudsen, et al.
Journal of Neuroscience (2022) Vol. 42, Iss. 45, pp. 8439-8449
Open Access | Times Cited: 45

Sustained effects of single doses of classical psychedelics in humans
Gitte M. Knudsen
Neuropsychopharmacology (2022) Vol. 48, Iss. 1, pp. 145-150
Open Access | Times Cited: 40

Psychedelic Commercialization: A Wide-Spanning Overview of the Emerging Psychedelic Industry
Jacob S. Aday, Brian S. Barnett, Dan Grossman, et al.
Psychedelic Medicine (2023) Vol. 1, Iss. 3, pp. 150-165
Closed Access | Times Cited: 22

Psilocybin for the treatment of Alzheimer’s disease
Siyi Zheng, Rong Ma, Yang Yang, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 7

Psychedelics as Novel Therapeutics in Alzheimer’s Disease: Rationale and Potential Mechanisms
Albert Garcia‐Romeu, Sean Darcy, Hillary Jackson, et al.
Current topics in behavioral neurosciences (2021), pp. 287-317
Closed Access | Times Cited: 25

Novel Psilocin Prodrugs with Altered Pharmacological Properties as Candidate Therapies for Treatment-Resistant Anxiety Disorders
Sheetal A. Raithatha, Jillian M. Hagel, Kaveh Matinkhoo, et al.
Journal of Medicinal Chemistry (2023) Vol. 67, Iss. 2, pp. 1024-1043
Open Access | Times Cited: 10

Overview and Specificity of Psilocybin Use in the Treatment of Mental Disorders: A Scientometric Analysis
Maria Helha Fernandes-Nascimento, Karine Viana-Ferreira, André Brooking Negrão
Psychedelic Medicine (2025)
Closed Access

Molecular brain imaging of psychedelic action
Paul Cumming, Klemens Egger, Gitte M. Knudsen
International review of neurobiology (2025)
Closed Access

Pharmacokinetics of Psilocybin: A Systematic Review
Shakila Meshkat, Huda Al-Shamali, Argyrios Perivolaris, et al.
Pharmaceutics (2025) Vol. 17, Iss. 4, pp. 411-411
Open Access

Cross-Species Evidence for Psilocin-induced Visual Distortions: Apparent Motion is Perceived by Both Humans and Rats
Čestmír Vejmola, Klára Šíchová, Kateřina Syrová, et al.
Biological Psychiatry Global Open Science (2025), pp. 100524-100524
Open Access

Neurobiology of the Antidepressant Effects of Serotonergic Psychedelics: A Narrative Review
Noah Chisamore, Erica Kaczmarek, Gia Han Le, et al.
Current Treatment Options in Psychiatry (2024) Vol. 11, Iss. 2, pp. 90-105
Closed Access | Times Cited: 3

A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT2A Receptor Density in the Pig Brain
Nakul Ravi Raval, Annette Johansen, Lene Lundgaard Donovan, et al.
(2020)
Open Access | Times Cited: 23

Bedside to bench: the outlook for psychedelic research
Victor P. Acero, Emily S. Cribas, Kevin D. Browne, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 7

Behavioural Investigations of Psilocybin in Animals 1962-2021: A Scoping Review
Ron Shore, K. Dobson, Nina Thomson, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2

Comparing psilocybin to metformin as neuroprotective agents against Parkinson's dementia: A systematic review of evidence and efficacy
Randall D Ordovich-Clarkson, Maurice Jabbour, Daniel Arteaga Pelayo, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024), pp. 111155-111155
Closed Access | Times Cited: 2

Utility of preclinical models in the study of psilocybin – A comprehensive review
Megan Pedicini, Zachary A. Cordner
Neuroscience & Biobehavioral Reviews (2023) Vol. 146, pp. 105046-105046
Closed Access | Times Cited: 6

Lysergic acid diethylamide induces increased signalling entropy in rats’ prefrontal cortex
Aurora Savino, Charles D. Nichols
Journal of Neurochemistry (2021) Vol. 162, Iss. 1, pp. 9-23
Open Access | Times Cited: 13

Serotonin 2A receptor function and depression-like behavior in rats model of hypothyroidism
Zhicheng Jin, Jianer Ling, Jing Yu, et al.
Experimental Brain Research (2021) Vol. 239, Iss. 8, pp. 2435-2444
Closed Access | Times Cited: 10

A transcriptomic analysis in mice following a single dose of ibogaine identifies new potential therapeutic targets
Judit Biosca-Brull, Genís Oña, Lineth Alarcón-Franco, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1

Pharmacokinetics of Psilocybin, a Tryptamine Alkaloid in Magic Mushroom ( Psilocybe cubensis ): A Systematic Review
Nilubon Thaoboonruang, Manupat Lohitnavy, Ornrat Lohitnavy
Journal of Psychoactive Drugs (2024), pp. 1-13
Closed Access | Times Cited: 1

A Multidisciplinary Hypothesis about Serotonergic Psychedelics. Is it Possible that a Portion of Brain Serotonin Comes From the Gut?
Noémi Császár-Nagy, Petr Bob, István Bókkon
Journal of Integrative Neuroscience (2022) Vol. 21, Iss. 5
Open Access | Times Cited: 5

Psilocybin Combines Rapid Synaptogenic And Anti-Inflammatory Effects In Vitro
Gabriella Smedfors, Elliot J. Glotfelty, Negar Kalani, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 4

Page 1 - Next Page

Scroll to top